BRIEF published on 05/21/2025 at 17:45, 11 days 12 hours ago DocMorris AG finalise son offre de droits de souscription avec une forte souscription Capital Social Stratégie De Croissance DocMorris AG Offre De Droits Médicaments Sur Ordonnance
BRIEF published on 05/21/2025 at 17:45, 11 days 12 hours ago DocMorris AG Completes Rights Offering with Strong Subscription Growth Strategy Share Capital DocMorris AG Rights Offering Prescription Medicines
PRESS RELEASE published on 05/21/2025 at 17:40, 11 days 12 hours ago DocMorris AG announces number of shares sold in rights offering DocMorris AG announces 98.7% of subscription rights exercised in rights offering, raising CHF 200 million in gross proceeds for planned growth and debt repayment Capital Increase Subscription Rights Swiss Exchange DocMorris AG Rights Offering
BRIEF published on 05/20/2025 at 13:35, 12 days 16 hours ago Pelion acquiert une participation dans DocMorris AG Investissement Soins De Santé Pharmacie Doc Morris Pelion
BRIEF published on 05/20/2025 at 13:35, 12 days 16 hours ago Pelion Acquires Stake in DocMorris AG Healthcare Investment Pharmacy DocMorris Pelion
PRESS RELEASE published on 05/20/2025 at 13:30, 12 days 16 hours ago Pelion invests in DocMorris Pelion, the largest healthcare company in Poland, acquires 9.68% stake in DocMorris AG, a leading online pharmacy. DocMorris welcomes the investment as a strategic move Healthcare Sector Investment Stake Acquisition DocMorris AG Pelion
BRIEF published on 05/08/2025 at 20:33, 24 days 9 hours ago Les actionnaires de DocMorris AG approuvent l'augmentation de capital Augmentation De Capital Approbation Des Actionnaires DocMorris AG Émission De Droits Médicaments Sur Ordonnance
BRIEF published on 05/08/2025 at 20:33, 24 days 9 hours ago DocMorris AG Shareholders Approve Capital Increase Capital Increase Rights Issue DocMorris AG Shareholders Approval Prescription Medicines
PRESS RELEASE published on 05/08/2025 at 20:28, 24 days 9 hours ago DocMorris AG shareholders approve capital increase and all proposals put forward by the Board of Directors DocMorris AG shareholders approve capital increase and all proposals at AGM, including rights issue to generate CHF 200 million for growth in Rx business Shareholders Capital Increase Rights Issue AGM DocMorris AG
BRIEF published on 05/08/2025 at 07:03, 24 days 23 hours ago DocMorris AG Finalizes AGM Agenda and Capital Increase Plans Annual General Meeting Revenue Growth Capital Increase Subscription Rights DocMorris AG
Published on 06/02/2025 at 01:00, 5 hours 10 minutes ago Sparta Capital Announces Filing of Interim Financial Statements
Published on 05/31/2025 at 06:16, 1 day 23 hours ago Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
Published on 05/31/2025 at 03:30, 2 days 2 hours ago Avant Brands Inc. Announces Voting Results From 2025 Annual General Meeting of Shareholders
Published on 05/31/2025 at 01:45, 2 days 4 hours ago GLG Life Tech Corporation Reports 2025 First Quarter Financial Results
Published on 05/30/2025 at 23:10, 2 days 7 hours ago CORRECTION: Nextech3D.ai Migrates MAP Dynamics to AWS, Enabling Scalable AI Architecture and Accelerated Deployment
Published on 06/01/2025 at 22:26, 7 hours 44 minutes ago KKR Increases Offer Price for Public Purchase Offer for DATAGROUP Shares conditional upon Final Acceptance Level, Best and Final Offer for DATAGROUP Shares Expires on 6 June 2025
Published on 06/01/2025 at 22:12, 7 hours 58 minutes ago EQS-Adhoc: DATAGROUP SE: KKR Increases Offer Price for Public Purchase Offer for DATAGROUP Shares conditional upon Final Acceptance Level
Published on 06/01/2025 at 10:00, 20 hours 10 minutes ago OPPO and the UEFA Champions League Final: Powering Football Innovation On and Off the Pitch
Published on 05/31/2025 at 21:00, 1 day 9 hours ago Leclanché annonce le dépôt d'une demande de prolongation du délai de publication du rapport annuel 2024 et la suspension temporaire de la cotation de ses actions nominatives à la SIX Swiss Exchange
Published on 05/31/2025 at 21:00, 1 day 9 hours ago Leclanché SA: Leclanché announces filing of request to extend the publication deadline for the 2024 Annual Report and the temporary suspension of trading of its registered shares on SIX Swiss Exchange
Published on 05/30/2025 at 18:14, 2 days 11 hours ago Emova Group - Rapport annuel de Durabilité 23/24
Published on 05/28/2025 at 23:00, 4 days 7 hours ago Standstill Commitments to hold shares of the company
Published on 05/28/2025 at 23:00, 4 days 7 hours ago Engagements collectifs de conservation de titres de la société
